For oncology nurses treating with BAVENCIO® (avelumab)

The nurse portal is your access point for information and resources that can help you effectively care for patients throughout BAVENCIO treatment.

SETTING PATIENT EXPECTATIONS

Providing your patients with a clear understanding of what to expect during BAVENCIO treatment and what to do in certain situations can help them be better prepared.

Before treatment, it may be helpful to discuss with your patients:

ADMINISTERING BAVENCIO IN YOUR PATIENTS

BAVENCIO is administered as an 800 mg IV infusion over 60 minutes every 2 weeks. 

Other important information to know about administration

  • Premedicate patients with an antihistamine and with acetaminophen prior to the first 4 infusions of BAVENCIO
  • Premedication should be administered for subsequent BAVENCIO doses based upon clinical judgment and presence/severity of prior infusion reactions 

See more on dosage and administration 

  • BAVENCIO can cause severe or life-threatening infusion-related reactions
  • Premedicate with antihistamine and acetaminophen prior to the first 4 infusions
  • Monitor patients for signs and symptoms of infusion-related reactions including:
    • pyrexia, chills, flushing, hypotension, dyspnea, wheezing, back pain, abdominal pain, and urticaria
MODIFY TREATMENT BASED ON SEVERITY
Grade 1-2 Grade 3-4
Interrupt or slow the rate of infusion Stop the infusion and permanently discontinue BAVENCIO

Learn more about managing infusion-related reactions

Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue and at any time after starting treatment, or after discontinuation. 

Discuss the importance of reporting any signs or symptoms of immune-mediated adverse reactions as soon as they occur

Learn about dose modifications for immune-mediate adverse reactions

See the BAVENCIO warnings and precautions

DOWNLOADABLE RESOURCES

Other downloadable resources to assist you in your practice